KovatchevB, CobelliC. Glucose variability: Timing, risk analysis, and relationship to hypoglycemia in diabetes. Diabetes Care, 2016; 39: 502–10.
2.
HirschIB. Glycemic variability and diabetes complications: does it matter? Of course it does!. Diabetes Care, 2015; 38: 1610–14.
3.
BergenstalRM. Glycemic variability and diabetes complications: does it matter? Simply put, there are better glycemic markers!. Diabetes Care, 2015; 38: 1615–21.
4.
FosterNC, MillerKM, TamborlaneWV, BergenstalRM, BeckRW; T1D Exchange Clinic Network. Continuous glucose monitoring in patients with type 1 diabetes using insulin injections. Diabetes Care, 2016; 39: e81–2.
5.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, TamborlaneWV, BeckRW, BodeBW, BuckinghamB, ChaseHP, ClemonsR, Fiallo-ScharerR, FoxLA, GilliamLK, HirschIB, HuangES, KollmanC, KowalskiAJ, LaffelL, LawrenceJM, LeeJ, MaurasN, O'GradyM, RuedyKJ, TanseyM, TsalikianE, WeinzimerS, WilsonDM, WolpertH, WysockiT, XingD. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med, 2008; 359: 1464–76.
6.
LindM, PolonskyW, HirschIB, HeiseT, BolinderJ, DahlqvistS, PehrssonNG, MoströmP. Design and methods of a randomized trial of continuous glucose monitoring in persons with type 1 diabetes with impaired glycemic control treated with multiple daily insulin injections (GOLD Study). J Diabetes Sci Technol, 2016; 10:754–61.
7.
BachmannS, HessM, Martin-DienerE, DenhaerynckK, ZumstegU. Nocturnal Hypoglycemia and physical activity in children with diabetes: new insights by continuous glucose monitoring and accelerometry. Diabetes Care, 2016; 39: e95–6.
8.
KargesB, KapellenT, WagnerVM, Steigleder-SchweigerC, KargesW, HollRW, RosenbauerJ; DPV Initiative. Glycated hemoglobin A1c as a risk factor for severe hypoglycemia in pediatric type 1 diabetes. Pediatr Diabetes, 2015; Dec29. doi:10.1111/pedi.12348. [Epub ahead of print]
9.
BratinaN, ShalitinS, PhillipM, BattelinoT. Type 1 Diabetes in the young: Organization of two national centers in Israel and Slovenia. Zdr Varst, 2015; 54: 139–45.
10.
PettusJ, EdelmanSV. Use of glucose rate of change arrows to adjust insulin therapy among individuals with type 1 diabetes who use continuous glucose monitoring. Diabetes Technol Ther, 2016; 18Suppl 2: S234–42.
11.
BattelinoT, OmladičJŠ, PhillipM. Closed loop insulin delivery in diabetes. Best Pract Res Clin Endocrinol Metab, 2015; 29: 315–25.
12.
ChoudharyP, OlsenBS, CongetI, WelshJB, VorrinkL, ShinJJ. Hypoglycemia prevention and user acceptance of an insulin pump system with predictive low glucose management. Diabetes Technol Ther, 2016; 18: 288–91.
13.
MaloneJI. Diabetic Central Neuropathy: CNS damage related to hyperglycemia. Diabetes, 2016; 65: 355–7.
14.
KurodaM, ShinkeT, OtakeH, SugiyamaD, TakayaT, TakahashiH, TerashitaD, UzuK, TaharaN, KashiwagiD, KurodaK, ShinkuraY, NagasawaY, SakaguchiK, HirotaY, OgawaW, HirataK. Effects of daily glucose fluctuations on the healing response to everolimus-eluting stent implantation as assessed using continuous glucose monitoring and optical coherence tomography. Cardiovasc Diabetol, 2016; 15: 79.
15.
FLAT-SUGAR Trial Investigators. Glucose variability in a 26-Week randomized comparison of mealtime treatment with rapid-acting insulin versus GLP-1 agonist in participants with type 2 diabetes at high cardiovascular risk. Diabetes Care, 2016; 39: 973–81.
16.
MarsoSP, DanielsGH, Brown-FrandsenK, KristensenP, MannJF, NauckMA, NissenSE, PocockS, PoulterNR, RavnLS, SteinbergWM, StocknerM, ZinmanB, BergenstalRM, Buse JB; LEADER Steering Committee; LEADER TrialInvestigators. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med, 2016; 375: 311–22.
17.
PfefferMA, ClaggettB, DiazR, DicksteinK, GersteinHC, KøberLV, LawsonFC, PingL, WeiX, LewisEF, MaggioniAP, McMurrayJJ, ProbstfieldJL, RiddleMC, SolomonSD, Tardif JC; ELIXAInvestigators. Lixisenatide in patients with type 2 diabetes and acute coronary syndrome. N Engl J Med, 2015; 373: 2247–57.
18.
RodbardD. Continuous Glucose Monitoring: A review of successes, challenges, and opportunities. Diabetes Technol Ther, 2016; 18Suppl 2: S23–213.
19.
KlemenčičS, de WitM, RutarM, BattelinoT, BratinaN. Annual psychological screening in youth and young adults with type 1 diabetes. Zdr Varst, 2015; 54: 103–11.
20.
PateT, KlemenčičS, BattelinoT, BratinaN. Fear of hypoglycemia, anxiety, and subjective well-being in parents of children and adolescents with type 1 diabetes. J Health Psychol, 2016; Jun7. [Epub ahead of print] pii: 1359105316650931
21.
DovčK, BratinaN, BattelinoT. A new horizon for glucose monitoring. Horm Res Paediatr, 2015; 83: 149–56.
